Kalos Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-405
| Closed | -$24K | – | 266 |
|
|
2020
Q3 | $24K | Hold |
405
| – | – | 0.01% | 229 |
|
|
2020
Q2 | $52K | Hold |
405
| – | – | 0.02% | 210 |
|
|
2020
Q1 | $24K | Buy |
405
+33
| +9% | +$1.96K | 0.01% | 201 |
|
|
2019
Q4 | $48K | Hold |
372
| – | – | 0.02% | 199 |
|
|
2019
Q3 | $46K | Hold |
372
| – | – | 0.02% | 193 |
|
|
2019
Q2 | $111K | Buy |
372
+18
| +5% | +$5.37K | 0.05% | 182 |
|
|
2019
Q1 | $159K | Sell |
354
-59
| -14% | -$26.5K | 0.1% | 141 |
|
|
2018
Q4 | $179K | Buy |
413
+25
| +6% | +$10.8K | 0.09% | 166 |
|
|
2018
Q3 | $308K | Buy |
388
+177
| +84% | +$141K | 0.17% | 117 |
|
|
2018
Q2 | $137K | Hold |
211
| – | – | 0.06% | 187 |
|
|
2018
Q1 | $137K | Buy |
+211
| New | +$137K | 0.08% | 112 |
|